Analysts Set Encompass Health Corporation (NYSE:EHC) Target Price at $142.86

Shares of Encompass Health Corporation (NYSE:EHC) have earned an average rating of “Buy” from the eleven analysts that are presently covering the company, MarketBeat reports. One investment analyst has rated the stock with a hold recommendation, eight have given a buy recommendation and two have given a strong buy recommendation to the company. The average 12-month price objective among brokerages that have updated their coverage on the stock in the last year is $142.8571.

A number of brokerages recently weighed in on EHC. Zacks Research lowered Encompass Health from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, November 19th. UBS Group boosted their price target on Encompass Health from $140.00 to $150.00 and gave the stock a “buy” rating in a report on Thursday, October 2nd. Barclays raised their price objective on shares of Encompass Health from $141.00 to $150.00 and gave the company an “overweight” rating in a report on Thursday, October 30th. KeyCorp boosted their target price on shares of Encompass Health from $135.00 to $140.00 and gave the stock an “overweight” rating in a report on Tuesday, September 16th. Finally, Raymond James Financial upgraded shares of Encompass Health to a “strong-buy” rating in a research report on Friday, October 31st.

Institutional Investors Weigh In On Encompass Health

A number of institutional investors have recently made changes to their positions in EHC. Alliancebernstein L.P. raised its position in shares of Encompass Health by 23.4% during the third quarter. Alliancebernstein L.P. now owns 2,515,878 shares of the company’s stock worth $319,567,000 after acquiring an additional 476,564 shares during the last quarter. T. Rowe Price Investment Management Inc. increased its position in Encompass Health by 25.6% during the 1st quarter. T. Rowe Price Investment Management Inc. now owns 2,080,918 shares of the company’s stock valued at $210,756,000 after purchasing an additional 424,691 shares during the period. Dimensional Fund Advisors LP raised its holdings in Encompass Health by 5.3% during the 1st quarter. Dimensional Fund Advisors LP now owns 1,871,581 shares of the company’s stock worth $189,549,000 after purchasing an additional 93,992 shares during the last quarter. Price T Rowe Associates Inc. MD lifted its position in shares of Encompass Health by 13.1% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 1,822,376 shares of the company’s stock worth $184,571,000 after purchasing an additional 211,707 shares during the period. Finally, Geode Capital Management LLC boosted its stake in shares of Encompass Health by 0.5% in the 2nd quarter. Geode Capital Management LLC now owns 1,773,547 shares of the company’s stock valued at $217,526,000 after purchasing an additional 8,765 shares during the last quarter. Institutional investors own 97.25% of the company’s stock.

Encompass Health Trading Down 1.2%

Shares of Encompass Health stock opened at $107.51 on Tuesday. The firm’s 50 day moving average is $116.21 and its 200 day moving average is $118.54. The firm has a market capitalization of $10.82 billion, a PE ratio of 20.32, a price-to-earnings-growth ratio of 1.92 and a beta of 0.73. Encompass Health has a 1 year low of $87.85 and a 1 year high of $127.99. The company has a current ratio of 1.14, a quick ratio of 1.14 and a debt-to-equity ratio of 0.76.

Encompass Health (NYSE:EHC) last issued its earnings results on Wednesday, March 16th. The company reported $0.93 earnings per share for the quarter. The firm had revenue of $136.30 million for the quarter. Encompass Health had a net margin of 9.33% and a return on equity of 17.84%. Encompass Health has set its FY22 guidance at $3.83-$4.19 EPS. Equities research analysts forecast that Encompass Health will post 4.8 earnings per share for the current fiscal year.

Encompass Health Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, January 15th. Investors of record on Friday, January 2nd will be given a dividend of $0.19 per share. This represents a $0.76 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend is Friday, January 2nd. Encompass Health’s dividend payout ratio (DPR) is currently 14.37%.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.